SCHEDULE 13D

Company

Nuo Therapeutics, Inc.

Filed

July 5, 2022

Accession Number

0001437749-22-016502

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →